Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion
โ Scribed by F. Figoli; M. L. Zanette; U. Tirelli; R. Sorio; C. Lestuzzi; R. Urso; S. Monfardini; M. D'Incalci
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 371 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Nine patients with ovarian carcinoma and malignant ascites treated with IV teniposide chemotherapy (30 mg/m2/30 min) entered this study. Plasma and peritoneal fluid levels were measured by an HPLC method with electrochemical detection. Plasma decay kinetics followed a triexponential function. A high
Twenty-two patients with malignant pericardial effusions were treated with subxiphoid partial pericardiectomy between 1984 and 1989. Thirteen patients also had a sclerosing agent instilled intrapericardially. Tamponade was relieved by pericardiocentesis before administration of general anesthesia. I